Trend
DailyUptrend (confirmed)
4 hourBearish
1 hourAscending Triangle
15 minBearish
5 minConsolidating
Daily trend turns down below $359.49
Key levels
Resistance$438.27
Resistance$413.70
Support$400.88
Support$386.88
Latest news & SEC filings
AnalystCitigroup keeps Buy rating on West Pharmaceutical, lifts target to $494
AnalystTD Cowen keeps Buy rating on West Pharmaceutical, lifts target to $500
All WST news →West Pharmaceutical Services supplies packaging and injection equipment used with injectable medicines and other healthcare goods. Its Proprietary Products unit makes rubber seals and stoppers, syringe and cartridge parts, vials, self-injection pens, and lab testing services for drugmakers, including makers of biologics and generics. Its Contract-Manufactured Products unit designs and assembles custom devices for clients in the medical, diagnostics, and drug industries. The company runs plants in the Americas, Europe, and Asia.
Based on the company's 10-K filed Feb 17, 2026.
NYSE · Healthcare
SEPT Low Target
$360.00
SEPT Mid Target
$431.00
SEPT High Target
$500.00
Analyst Consensus
$431.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for WST.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$333.67
66
Moat Score
NARROW
7/9
Piotroski Score
19.6
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
6.3%
3yr Revenue CAGR
2.1%
EPS Growth YoY
1.49%
FCF Growth YoY
69.7%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for WST, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:25:08 | $412.86 | 4,739 | $$2.0M | BUY |
| 21:28:26 | $412.86 | 1,107 | $$457K | BUY |
| 21:00:26 | $412.86 | 1,776 | $$733K | BUY |
| 20:54:05 | $414.32 | 1,000 | $$414K | SELL |
| 17:10:20 | $413.45 | 1,200 | $$496K | SELL |
5 dark pool trades shown · $$4.1M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for WEST PHARMACEUTICAL SERVICES INC (WST) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →WEST PHARMACEUTICAL SERVICES INC (WST) is at $411.30, down 0.38% (-$1.56) at the Nov 12, 2026 close.
Latest WST news — Oct 30, 2026: Citigroup keeps Buy rating on West Pharmaceutical, lifts target to $494 · Oct 30, 2026: TD Cowen keeps Buy rating on West Pharmaceutical, lifts target to $500
The average analyst price target for WST is $431.00, ranging from $360 to $500, based on 10 analysts. Latest: TD Cowen maintains on Oct 30, 2026.
Analyst ratings for WST: 4 Buy, 13 Hold, 0 Sell — consensus Hold.
WST last reported on Oct 29, 2026: EPS $2.66 vs $2.20 expected — a beat of 20.9%.
WST trades at a P/E of 46.3 vs a Healthcare average of 18.4.
Yes. WST's dividend yield is 0.31%.
WEST PHARMACEUTICAL SERVICES INC reported $203M of debt and $464M of cash (Sep 30, 2026).
Support: $400.88, $386.88, $372.79. Resistance: $413.70, $438.27, $460.11.
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
Oct 30, 2026: Citigroup keeps Buy rating on West Pharmaceutical, lifts target to $494 · Oct 30, 2026: TD Cowen keeps Buy rating on West Pharmaceutical, lifts target to $500